Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Molecular Autism
Published in: Molecular Autism 1/2022

Open Access 01-12-2022 | Intellectual Disability | Correction

Correction to: Visual attention and inhibitory control in children, teenagers and adults with autism without intellectual disability: results of oculomotor tasks from a 2-year longitudinal follow-up study (InFoR)

Authors: Anouck Amestoy, Etienne Guillaud, Giulia Bucchioni, Tiziana Zalla, Daniel Umbricht, Christopher Chatham, Lorraine Murtagh, Josselin Houenou, Richard Delorme, Myriam Ly-Le Moal, Marion Leboyer, Manuel Bouvard, Jean-René Cazalets

Published in: Molecular Autism | Issue 1/2022

Login to get access

Excerpt

Following publication of the original article [1], the authors identified 2 errors:
1.
An incorrect author name
a.
Incorrect name: Miriam Ly-Le Moal
 
b.
Correct name: Myriam Ly‐Le Moal
 
 
2.
The wrong affiliation was listed for Tiziana Zalla
a.
Incorrect affiliation: Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hofmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland.
 
b.
Correct affiliation: Institut Jean Nicod, ENS, Paris
 
 
The author group has been updated above, and the original article [1] has been corrected. …
Literature
1.
Metadata
Title
Correction to: Visual attention and inhibitory control in children, teenagers and adults with autism without intellectual disability: results of oculomotor tasks from a 2-year longitudinal follow-up study (InFoR)
Authors
Anouck Amestoy
Etienne Guillaud
Giulia Bucchioni
Tiziana Zalla
Daniel Umbricht
Christopher Chatham
Lorraine Murtagh
Josselin Houenou
Richard Delorme
Myriam Ly-Le Moal
Marion Leboyer
Manuel Bouvard
Jean-René Cazalets
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Molecular Autism / Issue 1/2022
Electronic ISSN: 2040-2392
DOI
https://doi.org/10.1186/s13229-021-00479-x

Other articles of this Issue 1/2022

Molecular Autism 1/2022 Go to the issue

Research

Infants later diagnosed with autism have lower canonical babbling ratios in the first year of life

Research

Autism-associated protein POGZ controls ESCs and ESC neural induction by association with esBAF

Research

Inter-individual heterogeneity of functional brain networks in children with autism spectrum disorder

Correction

Correction to: The relevance of the interpersonal theory of suicide for predicting past-year and lifetime suicidality in autistic adults

Research

Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome

Research

Globally elevated excitation–inhibition ratio in children with autism spectrum disorder and below-average intelligence